Phase II Study Design (B251)

24 mg/d; n = 110

12 mg/d; n = 110

4 mg/d; n = 108

1 mg/d; n = 107

Placebo; n = 113

Baseline

Week –4

Randomization

Week 4

Week 8

Week 12

Week 0

1

Previous slide

Next slide

Back to first slide

View graphic version